Entrada Therapeutics, Inc. (TRDA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 11:23AM EDT. Market open.
| Previous close | 11.85 |
| Open | 12.05 |
| Bid | 12.31 x 200 |
| Ask | 12.64 x 200 |
| Day's range | 12.05 - 12.52 |
| 52-week range | 10.62 - 18.44 |
| Volume | |
| Avg. volume | 77,513 |
| Market cap | 419.458M |
| Beta (5Y monthly) | -0.50 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.20 |
| Earnings date | 10 May 2024 - 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 21.00 |
GuruFocus.comDirector Peter Kim Acquires 9,048 Shares of Entrada Therapeutics Inc (TRDA)
Director Peter Kim of Entrada Therapeutics Inc (NASDAQ:TRDA) has recently increased his stake in the company.
Simply Wall St.Entrada Therapeutics, Inc. (NASDAQ:TRDA) Analysts Just Slashed This Year's Estimates
The analysts covering Entrada Therapeutics, Inc. ( NASDAQ:TRDA ) delivered a dose of negativity to shareholders today...
GuruFocus.comEntrada Therapeutics Inc (TRDA) Reports Solid Financial Position and Advancements in Clinical Trials
Extended Cash Runway and Progress in Duchenne Muscular Dystrophy Treatments Mark 2023 Milestones
© 2024 Yahoo. All rights reserved.